Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hymovis MO.RE.
- Development stage
- Unknown
- Lead developer
- Fidia Farmaceutici
- Modality
- Hydrogel Systems → Drug Delivery Systems
- Administration
- Intraarticular
01
Overview
Hymovis MO.RE. (Mobile Resilience) is a sterile, non-pyrogenic, viscoelastic hydrogel composed of a highly purified hyaluronic acid derivative (hexadecylamide of sodium hyaluronate, also known as HYADD4). Developed by Fidia Farmaceutici, it is specifically designed as a single-dose intra-articular injection for the treatment of pain in knee osteoarthritis, particularly for active patients or athletes suffering from overuse injuries. Unlike natural hyaluronic acid, the HYADD4 derivative features increased viscoelasticity and residence time in the joint due to its physical cross-linking properties, which allow it to act as a lubricant and shock absorber. It restores the rheological properties of the synovial fluid, facilitating joint mobility and reducing pain associated with mechanical stress.
- Brand names
- Hymovis MO.RE.Hymovis
- Other names
- Hymovis Mobile ResilienceHYADD4HYADD-4HYADD 4Hexadecylamide of sodium hyaluronate
Beyond the preview
Go deeper on Hymovis MO.RE..
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hymovis MO.RE..